Nikita Abramenko
Overview
Explore the profile of Nikita Abramenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vesela K, Kejik Z, Abramenko N, Kaplanek R, Jakubek M, Petrlova J
Front Med (Lausanne)
. 2024 Nov;
11:1478122.
PMID: 39534226
The concept of intratumoral microbiota is gaining attention in current research. Tumor-associated microbiota can activate oncogenic signaling pathways such as NF-κB, thereby promoting tumor development and progression. Numerous studies have...
2.
Kejik Z, Hajduch J, Abramenko N, Vellieux F, Vesela K, Leischner Fialova J, et al.
Commun Chem
. 2024 Aug;
7(1):180.
PMID: 39138299
Mitochondrial dysregulation plays a significant role in the carcinogenesis. On the other hand, its destabilization strongly represses the viability and metastatic potential of cancer cells. Photodynamic and photothermal therapies (PDT...
3.
Krol-Kulikowska M, Abramenko N, Jakubek M, Banasik M, Kepinska M
J Clin Med
. 2024 Feb;
13(4).
PMID: 38398308
Background: Angiotensin-converting enzyme (ACE) is responsible for the production of angiotensin II, and increased production of angiotensin II is observed in diabetes. What is more, polymorphisms may play a role...
4.
Abramenko N, Vellieux F, Vesela K, Kejik Z, Hajduch J, Masarik M, et al.
Sci Rep
. 2024 Feb;
14(1):3043.
PMID: 38321096
Immune checkpoints regulate the immune system response. Recent studies suggest that flavonoids, known as phytoestrogens, may inhibit the PD-1/PD-L1 axis. We explored the potential of estrogens and 17 Selective Estrogen...
5.
Kejik Z, Koubkova N, Krcova L, Sykora D, Abramenko N, Vesela K, et al.
Bioorg Chem
. 2023 Sep;
141:106816.
PMID: 37716274
Pentamethinium indolium salts are promising fluorescence probes and anticancer agents with high mitochondrial selectivity. We synthesized two indolium pentamethinium salts: a cyclic form with quinoxaline directly incorporated in the pentamethinium...
6.
Kaplanek R, Kejik Z, Hajduch J, Vesela K, Kucnirova K, Skalickova M, et al.
Biomed Pharmacother
. 2023 Aug;
166:115324.
PMID: 37598475
TET proteins (methylcytosine dioxygenases) play an important role in the regulation of gene expression. Dysregulation of their activity is associated with many serious pathogenic states such as oncological diseases. Regulation...
7.
Brogyanyi T, Kaplanek R, Kejik Z, Hosnedlova B, Antonyova V, Abramenko N, et al.
Biomed Pharmacother
. 2022 Sep;
155:113736.
PMID: 36156366
Dysregulation of iron homeostasis is one of the important processes in the development of many oncological diseases, such as pancreatic cancer. Targeting it with specific agents, such as an iron...
8.
Antonyova V, Tatar A, Brogyanyi T, Kejik Z, Kaplanek R, Vellieux F, et al.
Int J Mol Sci
. 2022 Sep;
23(18).
PMID: 36142763
Targeting of epigenetic mechanisms, such as the hydroxymethylation of DNA, has been intensively studied, with respect to the treatment of many serious pathologies, including oncological disorders. Recent studies demonstrated that...
9.
Leischner Fialova J, Honigova K, Raudenska M, Miksatkova L, Zobalova R, Navratil J, et al.
Biomed Pharmacother
. 2022 Sep;
154:113582.
PMID: 36055111
Mitochondria generate energy and building blocks required for cellular growth and function. The notion that mitochondria are not involved in the cancer growth has been challenged in recent years together...
10.
Talianova V, Kejik Z, Kaplanek R, Vesela K, Abramenko N, Lacina L, et al.
Pharmaceutics
. 2022 Aug;
14(8).
PMID: 36015338
IL-6 signaling is involved in the pathogenesis of a number of serious diseases, including chronic inflammation and cancer. Targeting of IL-6 receptor (IL-6R) by small molecules is therefore an intensively...